Navigation Links
ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
Date:9/8/2009

UTIONS

To minimize the risk of contamination, do not touch dropper tip to any surface. Keep bottle tightly closed when not in use.

Bepreve(TM) should not be used to treat contact lens-related irritation.

Remove contact lenses prior to instillation of Bepreve(TM).

ADVERSE REACTIONS

The most common reported adverse reaction occurring in approximately 25% of subjects was a mild taste following instillation. Other adverse reactions occurring in 2-5% of subjects were eye irritation, headache, and nasopharyngitis.

Full prescribing information is available on ISTA Pharmaceuticals' website at http://www.istavision.com

About ISTA Pharmaceuticals

ISTA Pharmaceuticals is the fourth largest branded ophthalmic pharmaceutical business in the U.S. ISTA's four marketed products plus its product candidates include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company is developing a strong product pipeline to fuel future growth and market share, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.

Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5%, Xibrom(TM) (bromfenac ophthalmic solution) 0.09%, and Istalol(R) (timolol maleate ophthalmic solution) 0.5% are trademarks of ISTA Pharmaceuticals.

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements. Without limiting the foregoing, but by way of example, statements contained in this press release
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies
2. LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
3. Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
4. Sagent Pharmaceuticals Announces Launch of Adenosine Injection, USP, in 6 mg per 2 mL Single-Dose Vials
5. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
6. NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting
7. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
8. Amira Pharmaceuticals Submits IND for Second DP2 Antagonist, AM461
9. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
10. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
11. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 Lazarus Effect, a medical device company ... facilitate removal of blood clots, announced the closing of ... support EU commercialization of several approved Lazarus Effect devices, ... and Lazarus Cover™ in the United States ... in the value of our novel, platform technology as ...
(Date:7/31/2014)... Colo. , July 31, 2014  Cannabis ... in cannabis formulation-based drug development and related consulting, ... production of multiple strains of cannabis and European ... to select the best strains for development of ... the cannabis formulations to market for critical ailments ...
(Date:7/31/2014)... July 31, 2014 For the first time, ... the implantation of the SynCardia temporary Total Artificial Heart ... video posted on the Journal of Visualized Experiments website. ... the paper on the SynCardia Total Artificial Heart implantation ... accompanies "Implantation of the SynCardia Total Artificial Heart," a ...
Breaking Medicine Technology:Lazarus Effect Closes $5 Million Financing 2Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3
(Date:7/31/2014)... Adventist Health System, which is ... Florida Hospital Tampa, Florida Hospital Carrollwood, Florida Hospital ... Pinellas, Florida Hospital Wesley Chapel, Florida Hospital Zephyrhills, ... Heartland Medical Center Lake Placid and Florida Hospital ... Most Wired Hospitals and Health Systems, which is ...
(Date:7/31/2014)... 2014 Hook Your Ex, a system created by ... feel emotionally hungry for their partner, to the point of starvation, ... little trick has been taught to hundreds of men and women ... Hook Your Ex review , Shane Michaels agrees this simple trick ... a breakup a second chance at getting back together with their ...
(Date:7/31/2014)... 31, 2014 United Theological Seminary is ... Anthony Le Donne and Peter J. Bellini. Both began ... to United is a Director of Non-Degree Programs, Mark ... , Anthony Le Donne, Assistant Professor of New Testament, ... teaches New Testament, Second Temple Judaism, and Greek courses. ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Cosmetic Town ... best Plastic Surgeons to consumers considering cosmetic treatments. ... their peers whose goal is to educate prospective patients ... are selected through a validated referral system that helps ... the best in their respective fields. , Cosmetic ...
(Date:7/31/2014)... The VitaSleep FDA cleared anti-snoring device ... an easier breathing capacity by slightly adjusting the position ... can breathe easier and helps reduce or even completely ... it can meet the needs of each individual snorer. ... by actual customer reviews. Johathan R. from Statham ...
Breaking Medicine News(10 mins):Health News:Florida Hospital West Florida Region is Among the Most Wired Hospitals and Health Systems in the United States 2Health News:Hook Your Ex Review by Shane Michaels Exposes Steve Pratt And His New Method For Getting Back With The Ex 2Health News:Growing Seminary Welcomes New Faculty 2Health News:The New Doctors’ Directory, Cosmetic Town Does the Research for Consumers of Plastic Surgeries 2Health News:New Dental Device Reviews to Stop Snoring by VitalSleep 2
... 2011) The Lymphoma Division of the John Theurer Cancer ... the Facebook groups "Hope for Lymphoma" and "Our MCL Family," ... November 12 from 8:30am 3:45pm. The event is ... Lymphoma (MCL) patients and their caregivers coping with this challenging ...
... EDITOR,S PICK: Connexins: providing protection to cells destroyed in ... a lifelong disease characterized by high levels of sugar ... patient,s immune system attacking and destroying the cells in ... blood glucose levels. Surprisingly, little is known about the ...
... , MONDAY, Nov. 7 (HealthDay News) -- People who believe ... it than those who think the rule has some wiggle room, ... a number of human behaviors and actions, including the Arab Spring ... in an upcoming issue of the journal Psychological Science . ...
... be published online Nov. 6 in Nature Medicine , ... that the development of osteoarthritis is in great part driven ... prevailing view attributing the condition to a lifetime of wear ... said William Robinson, MD, PhD, the study,s senior author, of ...
... Ore. After men become fathers for the first time, ... according to a new, 19-year study. Researchers assessed more ... to 31, and examined how men,s crime, tobacco, alcohol, and ... marriage can change a man,s negative behavior, they had not ...
... undergo radical prostatectomy get better results at teaching hospitals ... of an international study led by researchers at Henry ... that teaching hospitals always provide better care than others, ... characteristics that would explain the better results," says Quoc-Dien ...
Cached Medicine News:Health News:John Theurer Cancer Center to host inaugural Mantle Cell Lymphoma Symposium 2Health News:John Theurer Cancer Center to host inaugural Mantle Cell Lymphoma Symposium 3Health News:JCI online early table of contents: Nov. 7, 2011 2Health News:JCI online early table of contents: Nov. 7, 2011 3Health News:JCI online early table of contents: Nov. 7, 2011 4Health News:JCI online early table of contents: Nov. 7, 2011 5Health News:JCI online early table of contents: Nov. 7, 2011 6Health News:People Seem More Likely to Follow Rules They Can't Beat 2Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 2Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 3Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 4Health News:Fatherhood can help change a man's bad habits 2Health News:Prostate cancer surgery better at teaching hospitals 2
Cushing Little Joker periosteal elevators, solid handle, blade width 1/4" (6 mm), length 7 1/2" (191 mm)....
Molt 9 periosteal elevators....
Alexander periosteal elevators....
Lambotte periosteal elevators....
Medicine Products: